Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
HME News

Resmed receives FDA clearance for AI-enabled CPAP settings

Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort

Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
MassDevice

Resmed wins FDA clearance for AI-enabled personalized CPAP therapy device

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...
Fierce Biotech

FDA clears Resmed AI for personalizing CPAP settings

Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...
The Caledonian-Record

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as ...

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced ...
The Bull

ResMed (RMD) Gains FDA Nod for AI-Powered Sleep Apnea Therapy, Smart Comfort

ResMed has secured FDA clearance for its Personalized Therapy Comfort Settings (PTCS), branded as Smart Comfort - a ...